Management of coronary artery disease in patients with and without diabetes mellitus.: Acute management reasonable but secondary prevention unacceptably poor:: A report from the Euro Heart Survey on Diabetes and the heart

被引:47
作者
Anselmino, Matteo [1 ]
Bartnik, Malgorzata
Malmberg, Klas
Ryden, Lars
机构
[1] San Giovanni Battista Molinette Hosp, Dept Cardiol, I-10100 Turin, Italy
[2] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2007年 / 14卷 / 01期
关键词
clinical targets; coronary heart disease; diabetes mellitus; interventions; secondary prevention; treatment;
D O I
10.1097/01.hjr.0000199496.23838.83
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the diagnostic and therapeutic strategies applied to patients currently treated for coronary artery disease (CAD) in relation to the presence of diabetes mellitus (DM). Background Despite the declining mortality related to CAD, patients with DM have not experienced similar benefits and still have a deleterious prognosis compared to their non-DM counterparts. Methods The Euro Heart Survey on Diabetes and the Heart was conducted between February 2003 and January 2004 in 110 centres across 25 countries. Consecutive patients were recruited while referred to a cardiologist due to CAD, when admitted to hospital wards or visiting outpatient clinics. DM was defined as a diagnosis established before enrolment. Results DM was reported in 1524 (31%) of 4961 patients enrolled. Among the 1872 patients with acute coronary syndrome (ACS), adjusting for differences in clinical characteristics at baseline, DM status did not influence the propensity to use different pharmacological agents (except renin-angiotensin-aldosterone system blockers) or coronary interventions. In patients with stable CAD (n=2854) secondary prevention guidelines were poorly adhered to: 30% achieved blood pressure targets (<140/90 mmHg), and lipid control was adequate in a minority of DM and non-DM patients (total cholesterol > 5 mmol/l: 55 versus 47%; low-density lipoprotein cholesterol > 3 mmol/l: 57 versus 51%). Conclusions Differences in the treatment and intervention patterns of patients with ACS disappear when corrected for the clinical confounders detected. Despite the recommendations and the high cardiovascular risk, an inadequate and less aggressive management was demonstrated in the contemporary patients with diabetes and stable CAD compared with the non-diabetic counterparts.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 41 条
  • [31] RANDOMIZED TRIAL OF INSULIN-GLUCOSE INFUSION FOLLOWED BY SUBCUTANEOUS INSULIN-TREATMENT IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION (DIGAMI STUDY) - EFFECTS ON MORTALITY AT 1 YEAR
    MALMBERG, K
    RYDEN, L
    EFENDIC, S
    HERLITZ, J
    NICOL, P
    WALDENSTROM, A
    WEDEL, H
    WELIN, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (01) : 57 - 65
  • [32] Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes - Findings from the GUSTO-IIb Study
    McGuire, DK
    Emanuelsson, H
    Granger, CB
    Ohman, EM
    Moliterno, DJ
    White, HD
    Ardissino, D
    Box, JW
    Califf, RM
    Topol, EJ
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (21) : 1750 - 1758
  • [33] Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction
    Norhammar, A
    Malmberg, K
    Rydén, L
    Tornvall, P
    Stenestrand, U
    Wallentin, L
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (09) : 838 - 844
  • [34] Effect of carvedilol on survival in severe chronic heart failure.
    Packer, M
    Coats, AJS
    Fowler, MB
    Katus, HA
    Krum, H
    Mohacsi, P
    Rouleau, JL
    Tendera, M
    Castaigne, A
    Roecker, EB
    Schultz, MK
    DeMets, DL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) : 1651 - 1658
  • [35] EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL
    PFEFFER, MA
    BRAUNWALD, E
    MOYE, LA
    BASTA, L
    BROWN, EJ
    CUDDY, TE
    DAVIS, BR
    GELTMAN, EM
    GOLDMAN, S
    FLAKER, GC
    KLEIN, M
    LAMAS, GA
    PACKER, M
    ROULEAU, J
    ROULEAU, JL
    RUTHERFORD, J
    WERTHEIMER, JH
    HAWKINS, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) : 669 - 677
  • [36] Risk factor management in diabetic and non-diabetic patients with coronary heart disease.: Findings from the EUROASPIRE I and II surveys
    Pyörälä, K
    Lehto, S
    De Bacquer, D
    De Sutter, J
    Sans, S
    Keil, U
    Wood, D
    De Backer, G
    [J]. DIABETOLOGIA, 2004, 47 (07) : 1257 - 1265
  • [37] Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction -: The Munich registry
    Schnell, O
    Schäfer, O
    Kleybrink, S
    Doering, W
    Standl, E
    Otter, W
    [J]. DIABETES CARE, 2004, 27 (02) : 455 - 460
  • [38] Simoneau Guy G, DIABETES CARE, V17, P1411, DOI [10.2337/diacare.17.12.1411, DOI 10.2337/DIACARE.17.12.1411, DOI 10.2337/DIACARE.25.2007.S33]
  • [39] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [40] Wood D, 1998, EUR HEART J, V19, P1434